Now livetag icon
What will define the 2026 holiday season? 🔎 See how shoppers are deciding. Download the report →banner icon
Imugene

February 2026

Imugene Market Share Analysis for February 2026

Enquiry Form
Year Founded2013
Employees51 - 200
Annual Revenue$5M - $10M
imugene.com
Imugene
Imugene (including company regionals)
  • imugene.com
    imugene.com
See more website traffic and engagement information

Imugene Revenue up to February 2026 is 5M - 10M

revenue generated by Imugene top domains

Imugene top domains revenue over 3 years

Revenue for Imugene top domains


Total visits to Imugene's top domains

Understand Imugene market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Imugene's top domains

Analyze Imugene engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Imugene's top domains

See how Imugene keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Imugene

These are the website technologies, by industry, used by Imugene top domains

Advertising (5)

Google Adsense

Google Adsense

Social (5)

Instagram

Instagram

Widget (4)

Twemoji

Twemoji

Content Management System (3)

WordPress

WordPress

More Technologies

11

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Imugene

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImugene Limited attends event ASH 2025.Imugene abstract on azer-cel selected for oral presentation at ASH 2025.
NewsImugene Limited attended event European Society for Medical Oncology (ESMO) Congress 2025 on Oct 20th '25.Imugene Ltd (ASX:IMU, OTC:IUGNF) will showcase new data from its Neo-POLEM Phase II trial, investigating its PD1-Vaxx immunotherapy program in early-stage colorectal cancer, at this week's European Society for Medical Oncology (ESMO) Congress 2025 in Berlin - one of the world's leading forums for cancer research and innovation.
NewsImugene Limited receives award Notice of Allowance.Imugene (ASX:IMU) has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for its patent application number that protects its oncolytic virotherapy CF33-CD19 and its combination with CD19 targeting CAR-T cell therapies....

See all Imugene signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.